[company_age]25.0[/company_age][employees]51-200 employees[/employees][funding]Series unknown[/funding][description]BDD is a world-leading Contract Research Organisation (CRO) specializing in the development and clinical testing of innovative pharmaceutical products. They offer a unique combination of drug delivery expertise and clinical capabilities, enabling them to accelerate product development pipelines, manage product lifecycles, and create new value-added products. BDD's patented delayed release technology, OralogiK, provides unparalleled control over drug release at the desired location and time. Their clinical division offers a comprehensive package, including protocol development, study documentation design, regulatory authority submission, and production of ICH GCP-compliant clinical study reports. BDD specializes in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behavior of formulations. This technique, coupled with pharmacokinetic data, provides insights into the time and location of disintegration, gastric emptying, GI transit, and intra/inter-individual differences.[/description][ps]Drug delivery expertise, clinical capabilities, OralogiK delayed release technology, clinical trial services, gamma scintigraphy[/ps]